A detailed history of Armstrong Advisory Group, Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Armstrong Advisory Group, Inc holds 9,784 shares of ABBV stock, worth $1.74 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
9,784
Previous 9,833 0.5%
Holding current value
$1.74 Million
Previous $1.69 Million 14.59%
% of portfolio
0.16%
Previous 0.15%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$163.84 - $199.33 $8,028 - $9,767
-49 Reduced 0.5%
9,784 $1.93 Million
Q2 2024

Jul 12, 2024

SELL
$154.79 - $180.76 $59,748 - $69,773
-386 Reduced 3.78%
9,833 $1.69 Million
Q4 2023

Jan 17, 2024

SELL
$137.6 - $154.97 $26,006 - $29,289
-189 Reduced 1.82%
10,219 $1.58 Million
Q3 2023

Oct 11, 2023

BUY
$133.59 - $154.65 $14,026 - $16,238
105 Added 1.02%
10,408 $1.55 Million
Q2 2023

Jul 06, 2023

SELL
$132.51 - $164.9 $93,419 - $116,254
-705 Reduced 6.4%
10,303 $1.39 Million
Q1 2023

Apr 07, 2023

SELL
$144.61 - $166.54 $31,524 - $36,305
-218 Reduced 1.94%
11,008 $1.75 Million
Q4 2022

Jan 17, 2023

BUY
$138.31 - $165.87 $1.55 Million - $1.86 Million
11,226 New
11,226 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Armstrong Advisory Group, Inc Portfolio

Follow Armstrong Advisory Group, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armstrong Advisory Group, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Armstrong Advisory Group, Inc with notifications on news.